173 related articles for article (PubMed ID: 17637486)
1. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
[TBL] [Abstract][Full Text] [Related]
2. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
[TBL] [Abstract][Full Text] [Related]
3. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
[TBL] [Abstract][Full Text] [Related]
4. Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors.
Casañola-Martín GM; Marrero-Ponce Y; Tareq Hassan Khan M; Torrens F; Pérez-Giménez F; Rescigno A
J Biomol Screen; 2008 Dec; 13(10):1014-24. PubMed ID: 19015291
[TBL] [Abstract][Full Text] [Related]
5. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
6. Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation.
Casañola-Martin GM; Marrero-Ponce Y; Khan MT; Khan SB; Torrens F; Pérez-Jiménez F; Rescigno A; Abad C
Chem Biol Drug Des; 2010 Dec; 76(6):538-45. PubMed ID: 20964806
[TBL] [Abstract][Full Text] [Related]
7. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
[TBL] [Abstract][Full Text] [Related]
8. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
9. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
[TBL] [Abstract][Full Text] [Related]
10. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
[TBL] [Abstract][Full Text] [Related]
11. New tyrosinase inhibitors selected by atomic linear indices-based classification models.
Casañola-Martín GM; Khan MT; Marrero-Ponce Y; Ather A; Sultankhodzhaev MN; Torrens F
Bioorg Med Chem Lett; 2006 Jan; 16(2):324-30. PubMed ID: 16275084
[TBL] [Abstract][Full Text] [Related]
12. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
13. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
14. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis.
Castillo-Garit JA; Vega MC; Rolon M; Marrero-Ponce Y; Kouznetsov VV; Torres DF; Gómez-Barrio A; Bello AA; Montero A; Torrens F; Pérez-Giménez F
Eur J Pharm Sci; 2010 Jan; 39(1-3):30-6. PubMed ID: 19854271
[TBL] [Abstract][Full Text] [Related]
15. Classification of inhibitors of protein tyrosine phosphatase 1B using molecular structure based descriptors.
Patankar SJ; Jurs PC
J Chem Inf Comput Sci; 2003; 43(3):885-99. PubMed ID: 12767147
[TBL] [Abstract][Full Text] [Related]
16. A novel non-stochastic quadratic fingerprints-based approach for the 'in silico' discovery of new antitrypanosomal compounds.
Montero-Torres A; Vega MC; Marrero-Ponce Y; Rolón M; Gómez-Barrio A; Escario JA; Arán VJ; Martínez-Fernández AR; Meneses-Marcel A
Bioorg Med Chem; 2005 Nov; 13(22):6264-75. PubMed ID: 16115770
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
Marrero-Ponce Y; Siverio-Mota D; Gálvez-Llompart M; Recio MC; Giner RM; García-Domènech R; Torrens F; Arán VJ; Cordero-Maldonado ML; Esguera CV; de Witte PA; Crawford AD
Eur J Med Chem; 2011 Dec; 46(12):5736-53. PubMed ID: 22000935
[TBL] [Abstract][Full Text] [Related]
18. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.
Marrero-Ponce Y; Khan MT; Casañola-Martín GM; Ather A; Sultankhodzhaev MN; García-Domenech R; Torrens F; Rotondo R
J Comput Aided Mol Des; 2007 Apr; 21(4):167-88. PubMed ID: 17333484
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
[TBL] [Abstract][Full Text] [Related]
20. TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new herbicides.
Pérez González M; Gonzalez Díaz H; Molina Ruiz R; Cabrera MA; Ramos de Armas R
J Chem Inf Comput Sci; 2003; 43(4):1192-9. PubMed ID: 12870911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
